Coverage
-
October 11, 2023
A New York judge on Wednesday appointed two institutional investors to lead a proposed shareholder action alleging biopharma company Syneos Health lied about its booming business during the COVID-19 pandemic, saying that the pair's $51 million alleged loss gives them the biggest financial interest in the case.
1 other articles on this case.
View all »